Kiadis Pharma of the Netherlands has raised an additional €2 million from its initial public offering (IPO) of shares on the Euronext stock exchange in Amsterdam and Brussels following the partial exercise of an over-allotment option. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
